Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to -$122000.0.

  • Utah Medical Products' Exchange Rate Effect fell 13177.08% to -$122000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $48000.0, marking a year-over-year decrease of 8974.36%. This contributed to the annual value of -$677000.0 for FY2024, which is 29970.5% down from last year.
  • Per Utah Medical Products' latest filing, its Exchange Rate Effect stood at -$122000.0 for Q3 2025, which was down 13177.08% from $520000.0 recorded in Q2 2025.
  • Utah Medical Products' Exchange Rate Effect's 5-year high stood at $819000.0 during Q4 2022, with a 5-year trough of -$949000.0 in Q3 2022.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$11000.0 (2021), whereas its average is -$40105.3.
  • Data for Utah Medical Products' Exchange Rate Effect shows a peak YoY increase of 754545.45% (in 2022) and a maximum YoY decrease of 254137.93% (in 2022) over the last 5 years.
  • Utah Medical Products' Exchange Rate Effect (Quarter) stood at -$11000.0 in 2021, then surged by 7545.45% to $819000.0 in 2022, then plummeted by 40.42% to $488000.0 in 2023, then crashed by 234.63% to -$657000.0 in 2024, then surged by 81.43% to -$122000.0 in 2025.
  • Its Exchange Rate Effect was -$122000.0 in Q3 2025, compared to $520000.0 in Q2 2025 and $307000.0 in Q1 2025.